Cargando…
Severe muscle loss during radical chemoradiotherapy for non‐metastatic nasopharyngeal carcinoma predicts poor survival
BACKGROUND: Skeletal muscle loss is a novel imaging biomarker that is considered to be predictive of survival outcomes and toxicity in a variety of solid tumors. This study explored to investigate whether skeletal muscle loss after chemoradiotherapy (CRT) in nasopharyngeal carcinoma (NPC) patients c...
Autores principales: | Huang, Xiao, Ma, Jie, Li, Ling, Zhu, Xiao‐dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825977/ https://www.ncbi.nlm.nih.gov/pubmed/31517443 http://dx.doi.org/10.1002/cam4.2538 |
Ejemplares similares
-
The long-term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study
por: Fuwa, Nobukazu, et al.
Publicado: (2015) -
The effects of hemoglobin levels and their interactions with cigarette smoking on survival in nasopharyngeal carcinoma patients
por: Zeng, Qi, et al.
Publicado: (2016) -
Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020) -
Stage‐dependent conditional survival and failure hazard of non‐metastatic nasopharyngeal carcinoma after intensity‐modulated radiation therapy: Clinical implications for treatment strategies and surveillance
por: Wang, Jingbo, et al.
Publicado: (2021) -
Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer
por: Verma, Vivek, et al.
Publicado: (2018)